baylx | Media Room | PressRelease.com

Tagged baylx

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Press Release Dec 7, 2020

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics' continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company's collaboration with Baylx, Inc. (Baylx) to co-sponsor and spearhead the clinical trial of Baylx's FDA approved IND for COVID-19 indication using Human Umbilical Cord Tissue Mesenchymal Stem Cells (hUC-MSC) product, as featured by BioInformant on November 23, 2020. This publication can be seen in full at https://bioinformant.com/invitrx-baylx-covid-19. Read More

First
Prev

1

Next
Last